Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Receptor Binding and Downstream Signaling IGF-1 LR3 binds IGF1R with affinity similar to native IGF-1, preserving the receptor-level pharmacology while altering the pharmacokinetics
An 8-week on, 4-week off schedule provides predictable timing
A large number of studies have shown that the HGF/c-Met pathway is one of the most dysregulated pathways in human malignancies, which include, but are not limited to: bladder, breast, cervical, colorectal, endometrial, esophageal, gastric, head and neck, kidney, liver, lung, nasopharyngeal, ovarian, pancreatic, prostate, and thyroid cancers ( Lastly, an activating mutations of c-Met has been discovered in sporadic and inherited forms of human renal papillary carcinomas (Danilkovitch-Miagkova and Zbar, 2002)
For a full breakdown of what to anticipate by dose, see retatrutide side effects: what to expect
Perovic, D., Gojkovic, S., Jelic, M., et al
Afterwards, gently swirl or roll the vial between your hands
